Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan L Epstein

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Scientific Reports|July 24, 2021
Spatio-temporal biodistribution of <sup>89</sup>Zr-oxine labeled huLym-1-A-BB3z-CAR T-cells by PET imaging in a preclinical tumor modelNaomi S Sta Maria, Leslie A Khawli, Vyshnavi Pachipulusu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphomaMelissa G Lechner, Carolina Megiel, Connor H Church, et al.
Frontiers in Endocrinology|December 12, 2022
The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1Alessandro Salatino, Maria Mirabelli, Eusebio Chiefari, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 23, 2013
Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapyMelissa G Lechner, Saman S Karimi, Keegan Barry-Holson, et al.
Urology|February 5, 2013
Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1Sarah M Russell, Melissa G Lechner, Anusuya Mokashi, et al.
Aesthetic Surgery Journal|October 8, 2019
Comparative Analysis of Cytokines of Tumor Cell Lines, Malignant and Benign Effusions Around Breast ImplantsMarshall E Kadin, John Morgan, Nick Kouttab, et al.
Blood|February 8, 2022
Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced immunosuppressionXu Cao, Yingyu Wang, Wencan Zhang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Fc-mOX40L fusion protein produces complete remission and enhanced survival in 2 murine tumor modelsRebecca E Sadun, Wen-En Hsu, Nan Zhang, et al.
Aesthetic Surgery Journal|March 17, 2016
Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell LymphomaMarshall E Kadin, Anand Deva, Haiying Xu, et al.
Oral Oncology|July 2, 2011
USC-HN2, a new model cell line for recurrent oral cavity squamous cell carcinoma with immunosuppressive characteristicsSarah M Russell, Melissa G Lechner, Lucy Gong, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Scientific Reports|July 24, 2021
Spatio-temporal biodistribution of <sup>89</sup>Zr-oxine labeled huLym-1-A-BB3z-CAR T-cells by PET imaging in a preclinical tumor modelNaomi S Sta Maria, Leslie A Khawli, Vyshnavi Pachipulusu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphomaMelissa G Lechner, Carolina Megiel, Connor H Church, et al.
Frontiers in Endocrinology|December 12, 2022
The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1Alessandro Salatino, Maria Mirabelli, Eusebio Chiefari, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 23, 2013
Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapyMelissa G Lechner, Saman S Karimi, Keegan Barry-Holson, et al.
Urology|February 5, 2013
Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1Sarah M Russell, Melissa G Lechner, Anusuya Mokashi, et al.
Aesthetic Surgery Journal|October 8, 2019
Comparative Analysis of Cytokines of Tumor Cell Lines, Malignant and Benign Effusions Around Breast ImplantsMarshall E Kadin, John Morgan, Nick Kouttab, et al.
Blood|February 8, 2022
Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced immunosuppressionXu Cao, Yingyu Wang, Wencan Zhang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Fc-mOX40L fusion protein produces complete remission and enhanced survival in 2 murine tumor modelsRebecca E Sadun, Wen-En Hsu, Nan Zhang, et al.
Aesthetic Surgery Journal|March 17, 2016
Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell LymphomaMarshall E Kadin, Anand Deva, Haiying Xu, et al.
Oral Oncology|July 2, 2011
USC-HN2, a new model cell line for recurrent oral cavity squamous cell carcinoma with immunosuppressive characteristicsSarah M Russell, Melissa G Lechner, Lucy Gong, et al.
Pageof 10